Pharmacy benefit managers respond to FTC's lawsuit over insulin drug prices

preview_player
Показать описание
CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly inflating insulin prices.
Рекомендации по теме
Комментарии
Автор

The fact that insulin should only be at most $5 today and is cuttently.Over fifty dollars is a damned shame

teebone
Автор

Yeah... PBMs need to go. Nobody believes they are actually acting in the best interest of the insured

UmpaDuncdude